文献速递精神分裂症与精神病性障碍老年精神

精神分裂症衰老加速:五项病例对照研究

Accelerated Pace of Aging in Schizophrenia: Five Case-Control Studies.
PubMed 文献 · Biol Psychiatry · 2023-11-02

该研究汇总5项病例对照数据,用DunedinPACE算法评估精神分裂症患者与对照者的生物学衰老速度。共纳入1812例精神病性障碍患者和1753名对照,平均年龄38.9岁。结果显示精神分裂症与衰老加速一致相关,且不能归因于吸烟或氯氮平用药。

要点

  • 精神分裂症患者至中年期已伴随生物学衰老加速。
  • DunedinPACE测得的衰老加速与精神分裂症的关联不受吸烟或氯氮平影响。
  • 生物学衰老指标或有助于评估患者躯体与认知衰退风险及干预效果。

核心结论

  • 精神分裂症至中年期伴随生物学衰老加速,可能解释其多种年龄相关躯体疾病和痴呆风险增高。

研究设计与样本

  • 汇总5项病例对照数据集,计算基于DNA甲基化的DunedinPACE衰老速度指标。
  • 数据来自1812例精神病性障碍患者(精神分裂症或首发精神病)和1753名对照,平均实足年龄38.9岁(SD=13.6)。

主要发现

  • 各数据集均观察到精神分裂症与DunedinPACE测得的衰老加速一致相关。
  • 该关联不能归因于烟草吸烟或氯氮平用药。

临床怎么用

  • 生物学衰老指标可用于评估精神分裂症患者躯体与认知衰退风险。
  • 生物学衰老指标或可用于评价干预措施效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Schizophrenia is associated with increased risk of developing multiple aging-related diseases, including metabolic, respiratory, and cardiovascular diseases, and Alzheimer's and related dementias, leading to the hypothesis that schizophrenia is accompanied by accelerated biological aging. This has been difficult to test because there is no widely accepted measure of biological aging. Epigenetic clocks are promising algorithms that are used to calculate biological age on the basis of information from combined cytosine-phosphate-guanine sites (CpGs) across the genome, but they have yielded inconsistent and often negative results about the association between schizophrenia and accelerated aging. Here, we tested the schizophrenia-aging hypothesis using a DNA methylation measure that is uniquely designed to predict an individual's rate of aging. METHODS: We brought together 5 case-control datasets to calculate DunedinPACE (Pace of Aging Calculated from the Epigenome), a new measure trained on longitudinal data to detect differences between people in their pace of aging over time. Data were available from 1812 psychosis cases (schizophrenia or first-episode psychosis) and 1753 controls. Mean chronological age was 38.9 (SD = 13.6) years. RESULTS: We observed consistent associations across datasets between schizophrenia and accelerated aging as measured by DunedinPACE. These associations were not attributable to tobacco smoking or clozapine medication. CONCLUSIONS: Schizophrenia is accompanied by accelerated biological aging by midlife. This may explain the wide-ranging risk among people with schizophrenia for developing multiple different age-related physical diseases, including metabolic, respiratory, and cardiovascular diseases, and dementia. Measures of biological aging could prove valuable for assessing patients' risk for physical and cognitive decline and for evaluating intervention effectiveness.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Caspi A, Shireby G, Mill J, et al. Accelerated Pace of Aging in Schizophrenia: Five Case-Control Studies. Biol Psychiatry. 2023. PMID: 37924924. doi:10.1016/j.biopsych.2023.10.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。